Online Only Articles

Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial

University Hospital Heidelberg, Germany
Asklepios Hospital Hamburg Altona, Germany
Klinikum Chemnitz, Germany
University Hospital Heidelberg, Germany
University Hospital Heidelberg, Germany;National Center for Tumor Diseases Heidelberg, Germany
German Cancer Research Center Heidelberg, Germany
German Cancer Research Center Heidelberg, Germany
Charité Universitätsmedizin Berlin, Germany
University Hospital Cologne, Germany
University Hospital Heidelberg, Germany
University Hospital Heidelberg, Germany
Institute of Human Genetics, University of Heidelberg, Germany
University Hospital Heidelberg, Germany
University Hospital Heidelberg, Germany
University Hospital Heidelberg, Germany
University Medical Center Mainz, Germany
University Hospital Bonn, Germany
Helios Hospital Berlin Buch, Germany
Kath. Krankenhaus Hagen, Germany
Asklepios Hospital St. Georg Hamburgy, Germany
University Hospital Tübingen, Germany
University Hospital Essen, Germany
University Hospital Heidelberg, Germany;National Center for Tumor Diseases Heidelberg, Germany
Vol. 101 No. 12 (2016): December, 2016 https://doi.org/10.3324/haematol.2016.151266